Loomis, Sayles & Company’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$829M Sell
5,426,100
-108,115
-2% -$16.6M 1.12% 19
2025
Q4
$763M Sell
5,534,215
-130,696
-2% -$17.1M 0.92% 24
2025
Q3
$726M Buy
5,664,911
+83,335
+1% +$10.2M 0.86% 24
2025
Q2
$675M Buy
5,581,576
+78,483
+1% +$8.85M 0.85% 24
2025
Q1
$613M Sell
5,503,093
-73,868
-1% -$7.86M 0.89% 26
2024
Q4
$543M Sell
5,576,961
-192,677
-3% -$20.5M 0.69% 31
2024
Q3
$664M Sell
5,769,638
-175,745
-3% -$19.9M 0.87% 26
2024
Q2
$633M Buy
5,945,383
+27,411
+0.5% +$2.75M 0.87% 26
2024
Q1
$572M Sell
5,917,972
-91,928
-2% -$9.43M 0.81% 30
2023
Q4
$607M Sell
6,009,900
-56,717
-0.9% -$5.47M 0.93% 29
2023
Q3
$618M Sell
6,066,617
-248,393
-4% -$25.2M 1.06% 24
2023
Q2
$637M Sell
6,315,010
-292,139
-4% -$29.2M 1.03% 26
2023
Q1
$608M Sell
6,607,149
-4,338,849
-40% -$379M 1.05% 25
2022
Q4
$993M Sell
10,945,998
-3,983,754
-27% -$336M 1.99% 15
2022
Q3
$1.13B Sell
14,929,752
-555,468
-4% -$46M 2.3% 16
2022
Q2
$1.31B Sell
15,485,220
-1,821,967
-11% -$160M 2.43% 11
2022
Q1
$1.52B Sell
17,307,187
-586,379
-3% -$50.8M 2.03% 17
2021
Q4
$1.57B Sell
17,893,566
-1,045,879
-6% -$86.8M 1.89% 16
2021
Q3
$1.55B Sell
18,939,445
-80,144
-0.4% -$7.21M 1.9% 17
2021
Q2
$1.74B Sell
19,019,589
-749,188
-4% -$66.7M 2.1% 16
2021
Q1
$1.69B Sell
19,768,777
-348,952
-2% -$31.3M 2.19% 16
2020
Q4
$1.9B Buy
20,117,729
+9,611,979
+91% +$840M 2.51% 14
2020
Q3
$914M Sell
10,505,750
-38,369
-0.4% -$3.32M 1.33% 22
2020
Q2
$921M Buy
10,544,119
+136,363
+1% +$11.8M 1.48% 19
2020
Q1
$858M Buy
10,407,756
+142,624
+1% +$12.7M 1.77% 18
2019
Q4
$972M Buy
10,265,132
+3,162,317
+45% +$284M 1.65% 23
2019
Q3
$617M Buy
7,102,815
+74,679
+1% +$6.71M 1.19% 30
2019
Q2
$642M Sell
7,028,136
-796,514
-10% -$67.4M 1.2% 30
2019
Q1
$674M Buy
7,824,650
+52,660
+0.7% +$4.23M 1.32% 29
2018
Q4
$598M Sell
7,771,990
-426,056
-5% -$33.2M 1.41% 27
2018
Q3
$633M Buy
8,198,046
+152,022
+2% +$11.2M 1.24% 27
2018
Q2
$545M Sell
8,046,024
-661,104
-8% -$45.6M 1.1% 30
2018
Q1
$631M Buy
8,707,128
+990,113
+13% +$75.4M 1.34% 24
2017
Q4
$581M Buy
7,717,015
+128,096
+2% +$9.67M 1.21% 26
2017
Q3
$584M Buy
7,588,919
+188,039
+3% +$14.2M 1.28% 26
2017
Q2
$554M Buy
7,400,880
+435,657
+6% +$30.9M 1.31% 24
2017
Q1
$464M Buy
6,965,223
+46,607
+0.7% +$3.11M 1.16% 28
2016
Q4
$452M Buy
6,918,616
+389,527
+6% +$25.3M 1.11% 28
2016
Q3
$462M Buy
6,529,089
+278,138
+4% +$20.3M 1.17% 28
2016
Q2
$462M Buy
6,250,951
+399,821
+7% +$27.6M 1.26% 27
2016
Q1
$380M Buy
5,851,130
+456,413
+8% +$31.1M 1.08% 28
2015
Q4
$416M Buy
5,394,717
+261,017
+5% +$20.7M 1.17% 27
2015
Q3
$423M Buy
5,133,700
+360,385
+8% +$32.1M 1.25% 21
2015
Q2
$421M Buy
4,773,315
+740,534
+18% +$67.9M 1.16% 20
2015
Q1
$356M Buy
4,032,781
+128,535
+3% +$11.4M 0.99% 23
2014
Q4
$324M Buy
3,904,246
+76,469
+2% +$6.34M 0.9% 28
2014
Q3
$323M Buy
3,827,777
+409,881
+12% +$33.2M 0.95% 22
2014
Q2
$277M Buy
3,417,896
+207,950
+6% +$16.4M 0.79% 25
2014
Q1
$245M Buy
3,209,946
+940,287
+41% +$68.5M 0.69% 29
2013
Q4
$163M Buy
2,269,659
+23,041
+1% +$1.6M 0.49% 37
2013
Q3
$154M Buy
2,246,618
+1,281,789
+133% +$84.8M 0.5% 39
2013
Q2
$61.1K Buy
+964,829
New +$62.8M 0.22% 109

Other funds holding NVS